Long‐Term Antiplatelet Mono‐ and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta‐Analysis

摘要

Background The latest guidelines do not make clear recommendations on the selection of antiplatelet therapies for long‐term secondary prevention of stroke. We aimed to integrate the available evidence to create hierarchies of the comparative efficacy and safety of long‐term antiplatelet therapies after ischemic stroke or transient ischemic attack.